Citation only
via OpenAlex
Rhodiola rosea improves lifespan, locomotion, and neurodegeneration in a Drosophila melanogaster model of Huntington’s disease
Jasmin Grace Juanson Arabit, Rami Elhaj, SE Schriner, Evgueni A. Sevrioukov, Mahtab Jafari
Planta Medica · 2019 · ▲ 4 citations
Abstract
Huntington’s disease (HD) is a dominant, late-onset disease characterized by choreiform movements, cognitive decline, and personality disturbance. It is caused by a polyglutamine repeat expansion in the Huntington’s disease gene encoding for the Huntingtin protein (Htt) which functions as a scaffold for selective macroautophagy. Mutant Htt (mHtt) disrupts vesicle trafficking and prevents autophagosome fusion with lysosomes, thus deregulating autophagy(definition) in neuronal cells, leading to cell death. Autophagy has been described as a therapeutic target for HD, owing to the key role Htt plays in the cellular process. Rhodiola rosea , a plant extract used in traditional medicine in Europe and Asia, has been shown to attenuate aging in the fly and other model species. It has also been shown to inhibit the mTOR(definition) pathway and induce autophagy in bladder cancer cell lines. We hypothesized that R. rosea , by inducing autophagy, may improve the phenotype of a Huntington’s disease model of the fly. Flies expressing HttQ93 which exhibit decreased lifespan, impaired locomotion, and increased neurodegeneration were supplemented with R. rosea extract, and assays testing lifespan, locomotion, and pseudopupil degeneration provided quantitative measures of improvement. Based on our observations that the extract improves lifespan, locomotion, and neurodegeneration, R. rosea may be further evaluated as a potential therapy for Huntington’s disease. Fig. 1 The effect of R. rosea on the neurodegeneration of HD fly rhabdomeres. HD flies fed R. rosea exhibited significant rhabdomere count increases compared to control. Data analysis was performed using an analysis of variance (ANOVA) ∗p < 0.05, ∗∗∗∗p < 0.0001, n =.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1055/s-0039-3399705
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Arabit, J.G.J., Elhaj, R., Schriner, S., Sevrioukov, E.A., & Jafari, M. (2019). Rhodiola rosea improves lifespan, locomotion, and neurodegeneration in a Drosophila melanogaster model of Huntington’s disease. <em>Planta Medica</em>. https://doi.org/10.1055/s-0039-3399705
Vancouver
Arabit JGJ, Elhaj R, Schriner S, Sevrioukov EA, Jafari M. Rhodiola rosea improves lifespan, locomotion, and neurodegeneration in a Drosophila melanogaster model of Huntington’s disease. Planta Medica. 2019. doi:10.1055/s-0039-3399705.
BibTeX
@article{jasmin2019Rhodio,
title = {Rhodiola rosea improves lifespan, locomotion, and neurodegeneration in a Drosophila melanogaster model of Huntington’s disease},
author = {Jasmin Grace Juanson Arabit and Rami Elhaj and SE Schriner and Evgueni A. Sevrioukov and Mahtab Jafari},
journal = {Planta Medica},
year = {2019},
doi = {10.1055/s-0039-3399705},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BioMed Research International 2018
Open access · CC-BY
Rhodiola rosea Improves Lifespan, Locomotion, and Neurodegeneration in a Drosophila melanogaster Model of Huntington’s Disease
Nature Communications 2014
Open access · OA
A dual role for autophagy in a murine model of lung cancer
Cold Spring Harbor Perspectives in Biology 2011
Open access · OA
Huntington's Disease
Longevity & Healthspan 2013
Open access · CC-BY
Lifespan extension and delay of age-related functional decline caused by Rhodiola roseadepends on dietary macronutrient balance
Nature aging 2026
Citation only
Closing the gap in Alzheimer's disease research through the Sex | Gender in Neurodegeneration Consortium.
The Journal of Basic and Applied Zoology 2021
Open access · CC-BY